MRI for Hepatitis B-Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study

被引:0
作者
Sheng, Ruofan [1 ,2 ,3 ]
Wang, Heqing [3 ]
Zhang, Yunfei [2 ,4 ]
Sun, Wei [2 ]
Jin, Kaipu [1 ,2 ]
Dai, Yongming [4 ]
Zhang, Weiguo [5 ,8 ]
Zeng, Mengsu [1 ,2 ,6 ,7 ]
Zhou, Jianjun [1 ,3 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai 200032, Peoples R China
[2] Shanghai Inst Med Imaging, Shanghai 200032, Peoples R China
[3] Fudan Univ, Zhongshan Hosp Xiamen, Dept Radiol, Xiamen 361015, Peoples R China
[4] United Imaging Healthcare, Cent Res Inst, Shanghai 201800, Peoples R China
[5] Affiliated Soochow Univ, Dushu Lake Publ Hosp, Dept Radiol, Suzhou 215028, Peoples R China
[6] Fudan Univ, Zhongshan Hosp, Dept Canc Ctr, Shanghai 200032, Peoples R China
[7] Fudan Univ, Zhongshan Hosp, Dept Radiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[8] Suzhou Univ, Affiliated Hosp 1, Dept Radiol, Suzhou 215028, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 上海市自然科学基金;
关键词
intrahepatic cholangiocarcinoma; hepatitis B; diagnosis; comparative study; MASS-FORMING CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA; IMAGING FEATURES; CIRRHOSIS;
D O I
10.1002/jmri.28855
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background The diagnosis of intrahepatic cholangiocarcinoma (iCCA) is challenging in hepatitis B virus (HBV)-infected patients, due to the overlapping clinical manifestations and atypical imaging patterns compared to patients without HBV.Purpose To investigate the preoperative imaging characteristics of iCCA in patients with HBV in comparison to those without HBV.Study Type Retrospective.Subjects 431 patients with histopathologically confirmed iCCA (143 HBV-positive and 288 HBV-negative patients) were retrospectively enrolled from three institutes, and patients were allocated to the training (n = 302) and validation (n = 129) cohorts from different institutes or time period; 100 matching HBV-positive hepatocellular carcinoma (HCC) patients were also enrolled.Field Strength/Sequence 5-T and 3-T, including T1- and T2-weighted, diffusion-weighted and dynamic gadopentetate dimeglumine-enhanced imaging.Assessment Clinical and MRI features were analyzed and compared between HBV-positive and HBV-negative patients with iCCA, and between HBV-positive patients with iCCA and HCC.Statistical Tests Univariate and multivariate logistic regression analyses with odds ratio (OR) to identify independent features for discriminating HBV-associated iCCA. Diagnostic model generation by incorporating independent features, and the performance for discrimination was evaluated by receiver operating characteristics with the area under the curve (AUC) and 95% confidence interval (CI). AUCs were compared by the DeLong's method. A P-valueCompared to patients without HBV, washout or degressive enhancement pattern (OR = 51.837), well-defined tumor margin (OR = 8.758) and no peritumoral bile duct dilation (OR = 4.651) were independent significant features for discriminating HBV-associated iCCAs. All these features were also the predominant MRI manifestations for HBV-associated HCC. The combined index showed an AUC of 0.798 (95% CI 0.748-0.842) in the training cohort and an AUC of 0.789 (95% CI 0.708-0.856) in the validation cohort for discrimination. The sensitivity, specificity, and accuracy were all >70%, which was superior to each single feature alone in both cohorts.
引用
收藏
页码:1093 / 1104
页数:12
相关论文
共 29 条
  • [1] Interobserver agreement issues in radiology
    Benchoufi, M.
    Matzner-Lober, E.
    Molinari, N.
    Jannot, A-S
    Soyer, P.
    [J]. DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2020, 101 (10) : 639 - 641
  • [2] Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI
    Chen, Jie
    Wu, Zhenru
    Xia, Chunchao
    Jiang, Hanyu
    Liu, Xijiao
    Duan, Ting
    Cao, Likun
    Ye, Zheng
    Zhang, Zhen
    Ma, Ling
    Song, Bin
    Shi, Yujun
    [J]. EUROPEAN RADIOLOGY, 2020, 30 (02) : 1232 - 1242
  • [3] Contrast-enhanced multiple-phase imaging features of intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma with cirrhosis: A comparative study
    Chen, Ying
    Pan, Yao
    Shen, Ke-Ren
    Zhu, Xiu-Liang
    Lu, Chen-Ying
    Li, Qing-Hai
    Han, Shu-Gao
    Fu, Yan-Biao
    Xu, Xiu-Fang
    Yu, Ri-Sheng
    [J]. ONCOLOGY LETTERS, 2017, 14 (04) : 4213 - 4219
  • [4] Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
    Chernyak, Victoria
    Fowler, Kathryn J.
    Kamaya, Aya
    Kielar, Ania Z.
    Elsayes, Khaled M.
    Bashir, Mustafa R.
    Kono, Yuko
    Do, Richard K.
    Mitchell, Donald G.
    Singal, Amit G.
    Tang, An
    Sirlin, Claude B.
    [J]. RADIOLOGY, 2018, 289 (03) : 816 - 830
  • [5] LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI
    Choi, Sang Hyun
    Lee, Seung Soo
    Park, So Hyun
    Kim, Kang Mo
    Yu, Eunsil
    Park, Yangsoon
    Shin, Yong Moon
    Lee, Moon-Gyu
    [J]. RADIOLOGY, 2019, 290 (02) : 388 - 397
  • [6] Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging
    Choi, Seo-Youn
    Kim, Young Kon
    Min, Ji Hye
    Kang, Tae Wook
    Jeong, Woo Kyoung
    Ahn, Soohyun
    Won, Hojeong
    [J]. EUROPEAN RADIOLOGY, 2018, 28 (06) : 2549 - 2560
  • [7] Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study
    Choi, Seo-Youn
    Kim, Seong Hyun
    Park, Cheol Keun
    Min, Ji Hye
    Lee, Ji Eun
    Choi, Yoon-Hyeong
    Lee, Bo Ra
    [J]. RADIOLOGY, 2018, 286 (03) : 917 - 928
  • [8] Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
    Clements, Oliver
    Eliahoo, Joseph
    Kim, Jin Un
    Taylor-Robinson, Simon D.
    Khan, Shahid A.
    [J]. JOURNAL OF HEPATOLOGY, 2020, 72 (01) : 95 - 103
  • [9] Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?
    Fragkou, Nikolaos
    Sideras, Lazaros
    Panas, Panteleimon
    Emmanouilides, Christos
    Sinakos, Emmanouil
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (27) : 4252 - 4275
  • [10] Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
    Gutierrez-Larranaga, Maria
    Gonzalez-Lopez, Elena
    Roa-Bautista, Adriel
    Rodrigues, Pedro M.
    Diaz-Gonzalez, Alvaro
    Banales, Jesus M.
    Lopez-Hoyos, Marcos
    Santos-Laso, Alvaro
    Crespo, Javier
    [J]. LIVER CANCER, 2021, 10 (06) : 545 - 560